UniProt ID | PRKRA_HUMAN | |
---|---|---|
UniProt AC | O75569 | |
Protein Name | Interferon-inducible double-stranded RNA-dependent protein kinase activator A | |
Gene Name | PRKRA | |
Organism | Homo sapiens (Human). | |
Sequence Length | 313 | |
Subcellular Localization | Cytoplasm, perinuclear region. Cytoplasm. | |
Protein Description | Activates EIF2AK2/PKR in the absence of double-stranded RNA (dsRNA), leading to phosphorylation of EIF2S1/EFI2-alpha and inhibition of translation and induction of apoptosis. Required for siRNA production by DICER1 and for subsequent siRNA-mediated post-transcriptional gene silencing. Does not seem to be required for processing of pre-miRNA to miRNA by DICER1. Promotes UBC9-p53/TP53 association and sumoylation and phosphorylation of p53/TP53 at 'Lys-386' at 'Ser-392' respectively and enhances its activity in a EIF2AK2/PKR-dependent manner (By similarity).. | |
Protein Sequence | MSQSRHRAEAPPLEREDSGTFSLGKMITAKPGKTPIQVLHEYGMKTKNIPVYECERSDVQIHVPTFTFRVTVGDITCTGEGTSKKLAKHRAAEAAINILKANASICFAVPDPLMPDPSKQPKNQLNPIGSLQELAIHHGWRLPEYTLSQEGGPAHKREYTTICRLESFMETGKGASKKQAKRNAAEKFLAKFSNISPENHISLTNVVGHSLGCTWHSLRNSPGEKINLLKRSLLSIPNTDYIQLLSEIAKEQGFNITYLDIDELSANGQYQCLAELSTSPITVCHGSGISCGNAQSDAAHNALQYLKIIAERK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSQSRHRAE ------CCCCCCCCC | 36.54 | 19413330 | |
2 | Phosphorylation | ------MSQSRHRAE ------CCCCCCCCC | 36.54 | 26074081 | |
4 | Phosphorylation | ----MSQSRHRAEAP ----CCCCCCCCCCC | 23.81 | 25159151 | |
11 (in isoform 2) | Phosphorylation | - | 26.05 | 25693802 | |
18 | Phosphorylation | PPLEREDSGTFSLGK CCCCCCCCCCEEECC | 34.67 | 29255136 | |
20 | Phosphorylation | LEREDSGTFSLGKMI CCCCCCCCEEECCEE | 17.63 | 29255136 | |
22 | Phosphorylation | REDSGTFSLGKMITA CCCCCCEEECCEEEC | 35.73 | 29255136 | |
25 | Acetylation | SGTFSLGKMITAKPG CCCEEECCEEECCCC | 32.21 | 25953088 | |
28 | Phosphorylation | FSLGKMITAKPGKTP EEECCEEECCCCCCC | 25.73 | 26074081 | |
30 | Ubiquitination | LGKMITAKPGKTPIQ ECCEEECCCCCCCHH | 45.73 | - | |
34 | Phosphorylation | ITAKPGKTPIQVLHE EECCCCCCCHHHHHH | 31.38 | 20068231 | |
42 | Phosphorylation | PIQVLHEYGMKTKNI CHHHHHHCCCCCCCC | 16.27 | 27642862 | |
45 | Acetylation | VLHEYGMKTKNIPVY HHHHCCCCCCCCCEE | 52.57 | 25953088 | |
45 | Ubiquitination | VLHEYGMKTKNIPVY HHHHCCCCCCCCCEE | 52.57 | - | |
47 | Ubiquitination | HEYGMKTKNIPVYEC HHCCCCCCCCCEEEE | 47.57 | - | |
52 | Phosphorylation | KTKNIPVYECERSDV CCCCCCEEEEECCCC | 14.98 | 28796482 | |
67 | Phosphorylation | QIHVPTFTFRVTVGD EEECCEEEEEEEECC | 17.01 | - | |
71 | Phosphorylation | PTFTFRVTVGDITCT CEEEEEEEECCEEEE | 17.95 | 20068231 | |
76 | Phosphorylation | RVTVGDITCTGEGTS EEEECCEEEECCCCC | 14.57 | 21406692 | |
78 | Phosphorylation | TVGDITCTGEGTSKK EECCEEEECCCCCHH | 29.62 | 20068231 | |
82 | Phosphorylation | ITCTGEGTSKKLAKH EEEECCCCCHHHHHH | 32.82 | 20068231 | |
83 | Phosphorylation | TCTGEGTSKKLAKHR EEECCCCCHHHHHHH | 38.35 | 21406692 | |
84 | Acetylation | CTGEGTSKKLAKHRA EECCCCCHHHHHHHH | 52.20 | 25953088 | |
84 | Ubiquitination | CTGEGTSKKLAKHRA EECCCCCHHHHHHHH | 52.20 | - | |
85 | Ubiquitination | TGEGTSKKLAKHRAA ECCCCCHHHHHHHHH | 54.14 | - | |
104 | Phosphorylation | NILKANASICFAVPD HHHHHCCEEEEEECC | 21.50 | 30622161 | |
130 | Phosphorylation | NQLNPIGSLQELAIH CCCCCCCCHHHHHHH | 27.83 | 28464451 | |
145 | Phosphorylation | HGWRLPEYTLSQEGG CCCCCCCCCCCCCCC | 15.84 | 28796482 | |
146 | Phosphorylation | GWRLPEYTLSQEGGP CCCCCCCCCCCCCCC | 20.47 | 28796482 | |
148 | Phosphorylation | RLPEYTLSQEGGPAH CCCCCCCCCCCCCCC | 20.56 | 28857561 | |
156 | Ubiquitination | QEGGPAHKREYTTIC CCCCCCCCCEEEEEE | 49.37 | - | |
159 | Phosphorylation | GPAHKREYTTICRLE CCCCCCEEEEEEEHH | 17.14 | 28796482 | |
160 | Phosphorylation | PAHKREYTTICRLES CCCCCEEEEEEEHHH | 12.63 | 26552605 | |
161 | Phosphorylation | AHKREYTTICRLESF CCCCEEEEEEEHHHH | 19.71 | 21130716 | |
167 | Phosphorylation | TTICRLESFMETGKG EEEEEHHHHHHHCCC | 34.19 | 30266825 | |
171 | Phosphorylation | RLESFMETGKGASKK EHHHHHHHCCCCCHH | 32.19 | 23312004 | |
173 | Ubiquitination | ESFMETGKGASKKQA HHHHHHCCCCCHHHH | 59.74 | - | |
176 | Phosphorylation | METGKGASKKQAKRN HHHCCCCCHHHHHHH | 49.40 | 21130716 | |
177 | Ubiquitination | ETGKGASKKQAKRNA HHCCCCCHHHHHHHH | 48.66 | - | |
187 | Acetylation | AKRNAAEKFLAKFSN HHHHHHHHHHHHHCC | 40.74 | 25953088 | |
187 | Ubiquitination | AKRNAAEKFLAKFSN HHHHHHHHHHHHHCC | 40.74 | - | |
196 | Phosphorylation | LAKFSNISPENHISL HHHHCCCCCCCCEEH | 30.34 | 27251275 | |
202 | Phosphorylation | ISPENHISLTNVVGH CCCCCCEEHHHHHHH | 22.91 | 27251275 | |
210 | Phosphorylation | LTNVVGHSLGCTWHS HHHHHHHHCCCCHHH | 22.11 | 27251275 | |
214 | Phosphorylation | VGHSLGCTWHSLRNS HHHHCCCCHHHHCCC | 25.14 | 27251275 | |
217 | Phosphorylation | SLGCTWHSLRNSPGE HCCCCHHHHCCCCHH | 22.15 | 28857561 | |
221 | Phosphorylation | TWHSLRNSPGEKINL CHHHHCCCCHHHHHH | 28.04 | 29214152 | |
225 | Ubiquitination | LRNSPGEKINLLKRS HCCCCHHHHHHHHHH | 42.69 | - | |
232 | Phosphorylation | KINLLKRSLLSIPNT HHHHHHHHHHCCCCC | 31.88 | 28857561 | |
235 | Phosphorylation | LLKRSLLSIPNTDYI HHHHHHHCCCCCHHH | 41.09 | 25693802 | |
241 | Phosphorylation | LSIPNTDYIQLLSEI HCCCCCHHHHHHHHH | 6.63 | - | |
246 | Phosphorylation | TDYIQLLSEIAKEQG CHHHHHHHHHHHHCC | 35.23 | 21526770 | |
270 | Phosphorylation | ELSANGQYQCLAELS HHCCCCCEEEEEECC | 11.55 | 22817900 | |
287 | Phosphorylation | PITVCHGSGISCGNA CEEEEECCCCCCCCC | 14.86 | 21526770 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PRKRA_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PRKRA_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
612067 | Dystonia 16 (DYT16) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND MASSSPECTROMETRY. | |
"Phosphorylation of specific serine residues in the PKR activationdomain of PACT is essential for its ability to mediate apoptosis."; Peters G.A., Li S., Sen G.C.; J. Biol. Chem. 281:35129-35136(2006). Cited for: FUNCTION, INTERACTION WITH EIF2AK2, SUBCELLULAR LOCATION,PHOSPHORYLATION AT SER-246 AND SER-287, AND MUTAGENESIS OF SER-18;GLN-243; SER-246; ASP-260; ASP-262; SER-265; GLN-271; SER-279;SER-287; GLY-288 AND CYS-291. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND MASSSPECTROMETRY. |